Mastodon

Daigo Jointic (Capsules) Instructions for Use

Marketing Authorization Holder

Metabiotic, LLC (Russia)

Manufactured By

PNK Farmaceutici, S.p.A. (Italy)

Contact Information

B and S Corporation Co. Ltd. (Japan)

Dosage Form

Bottle OTC Icon Daigo Jointic Capsules: 60 pcs.

Dosage Form, Packaging, and Product Composition

Capsules with a mass of 0.584 g.

2 caps.
Chlorella peptide IPH C 140 mg
L-Glutamine 52.5 mg
L-Isoleucine 52.5 mg
L-leucine 52.5 mg
L-arginine hydrochloride 52.5 mg
Palmitoylethanolamide 325 mg
Lipolytic enzymes (lipases) 200 mg
Ascorbic acid (vit. C) 50 mg
Boron 0.662 mg
Manganese 2 mg
Chromium 0.05 mg

15 pcs. – blisters (4) – cardboard packs.

Therapeutic Category

Dietary supplement for supporting the function of the musculoskeletal system

Properties

The components included in the composition of Daigo Jointic contribute to the improvement of joint function, strengthening of cartilage, bone, and muscle tissue.

The preparation increases physical endurance and training effectiveness.

The preparation is suitable as an additional means for rehabilitation in terms of joint pathology, for strengthening joints in people with excess body weight.

The preparation can also be used after a period of forced hypodynamia (for example, due to injuries, after infectious diseases, etc.).

Scope of Application

Of the Daigo Jointic product

  • As a dietary supplement – a source of Chlorella peptide IPH C, L-glutamic acid, L-isoleucine, L-leucine, L-arginine, palmitoylethanolamide, vitamin C, boron, manganese, chromium, lipase enzyme.

ICD codes

ICD-10 code Indication
E63 Other nutritional deficiencies

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Orally, with meals.

Adults take 1 capsule 2 times/day. The duration of administration is 1 month. If necessary, the course can be repeated.

Side Effects

None identified.

Contraindications

  • Individual intolerance to the product components;
  • Pregnancy;
  • Breastfeeding period.

Use During Pregnancy and Breastfeeding

Use during pregnancy and breastfeeding is contraindicated.

Special Instructions

A dietary supplement, not a medicinal product.

It is recommended to consult a doctor before use.

Dispensing Status

Places of sale are determined by the national legislation of the member states of the Eurasian Economic Union.

Storage Conditions

The product should be stored in a dry place, protected from direct sunlight, out of reach of children, at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 5 years from the date of manufacture.

After opening, store tightly closed under the same conditions.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS